 |
Previous Article | Next Article 
The Journal of Neuroscience, June 1, 2002, 22(11):4720-4727
9-Tetrahydrocannabinol and Cannabinol Activate
Capsaicin-Sensitive Sensory Nerves via a CB1 and
CB2 Cannabinoid Receptor-Independent Mechanism
Peter M.
Zygmunt,
David A.
Andersson, and
Edward D.
Högestätt
Department of Clinical Pharmacology, Institute of Laboratory
Medicine, Lund University Hospital, SE-221 85 Lund, Sweden
Although 9-tetrahydrocannabinol (THC) produces
analgesia, its effects on nociceptive primary afferents are unknown.
These neurons participate not only in pain signaling but also in the local response to tissue injury. Here, we show that THC and cannabinol induce a CB1/CB2 cannabinoid
receptor-independent release of calcitonin gene-related peptide from
capsaicin-sensitive perivascular sensory nerves. Other psychotropic
cannabinoids cannot mimic this action. The vanilloid receptor
antagonist ruthenium red abolishes the responses to THC and cannabinol.
However, the effect of THC on sensory nerves is intact in vanilloid
receptor subtype 1 gene knock-out mice. The THC response depends on
extracellular calcium but does not involve known voltage-operated
calcium channels, glutamate receptors, or protein kinases A and C. These results may indicate the presence of a novel cannabinoid
receptor/ion channel in the pain pathway.
Key words:
calcitonin gene-related peptide; cannabinoids; cannabinol; cannabis; capsaicin; nociceptors; pain; receptors, sensory; tetrahydrocannabinol
Copyright © 2002 Society for Neuroscience 0270-6474/02/22114720-08$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
A. E. B. Springs, P. W. F. Karmaus, R. B. Crawford, B. L. F. Kaplan, and N. E. Kaminski
Effects of targeted deletion of cannabinoid receptors CB1 and CB2 on immune competence and sensitivity to immune modulation by {Delta}9-tetrahydrocannabinol
J. Leukoc. Biol.,
December 1, 2008;
84(6):
1574 - 1584.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Qin, M. P. Neeper, Y. Liu, T. L. Hutchinson, M. L. Lubin, and C. M. Flores
TRPV2 Is Activated by Cannabidiol and Mediates CGRP Release in Cultured Rat Dorsal Root Ganglion Neurons
J. Neurosci.,
June 11, 2008;
28(24):
6231 - 6238.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. De Petrocellis, V. Vellani, A. Schiano-Moriello, P. Marini, P. C. Magherini, P. Orlando, and V. Di Marzo
Plant-Derived Cannabinoids Modulate the Activity of Transient Receptor Potential Channels of Ankyrin Type-1 and Melastatin Type-8
J. Pharmacol. Exp. Ther.,
June 1, 2008;
325(3):
1007 - 1015.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A.H. Taylor, C. Ang, S.C. Bell, and J.C. Konje
The role of the endocannabinoid system in gametogenesis, implantation and early pregnancy
Hum. Reprod. Update,
September 1, 2007;
13(5):
501 - 513.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. D. Giudice, L. Rinaldi, M. Passarotto, F. Facchinetti, A. D'Arrigo, A. Guiotto, M. D. Carbonare, L. Battistin, and A. Leon
Cannabidiol, unlike synthetic cannabinoids, triggers activation of RBL-2H3 mast cells
J. Leukoc. Biol.,
June 1, 2007;
81(6):
1512 - 1522.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. E. O'Sullivan, M. D. Randall, and S. M. Gardiner
The in Vitro and in Vivo Cardiovascular Effects of {Delta}9-Tetrahydrocannabinol in Rats Made Hypertensive by Chronic Inhibition of Nitric-Oxide Synthase
J. Pharmacol. Exp. Ther.,
May 1, 2007;
321(2):
663 - 672.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. E. O'Sullivan, D. A. Kendall, and M. D. Randall
Further Characterization of the Time-Dependent Vascular Effects of {Delta}9-Tetrahydrocannabinol
J. Pharmacol. Exp. Ther.,
April 1, 2006;
317(1):
428 - 438.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Movahed, B. A. G. Jonsson, B. Birnir, J. A. Wingstrand, T. D. Jorgensen, A. Ermund, O. Sterner, P. M. Zygmunt, and E. D. Hogestatt
Endogenous Unsaturated C18 N-Acylethanolamines Are Vanilloid Receptor (TRPV1) Agonists
J. Biol. Chem.,
November 18, 2005;
280(46):
38496 - 38504.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. M. Bautista, P. Movahed, A. Hinman, H. E. Axelsson, O. Sterner, E. D. Hogestatt, D. Julius, S.-E. Jordt, and P. M. Zygmunt
Pungent products from garlic activate the sensory ion channel TRPA1
PNAS,
August 23, 2005;
102(34):
12248 - 12252.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Duncan, D. A. Kendall, and V. Ralevic
Characterization of Cannabinoid Modulation of Sensory Neurotransmission in the Rat Isolated Mesenteric Arterial Bed
J. Pharmacol. Exp. Ther.,
October 1, 2004;
311(1):
411 - 419.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Pacher, S. Batkai, and G. Kunos
Haemodynamic profile and responsiveness to anandamide of TRPV1 receptor knock-out mice
J. Physiol.,
July 15, 2004;
558(2):
647 - 657.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Dubrovska, S. Verlohren, F. C. Luft, and M. Gollasch
Mechanisms of ADRF release from rat aortic adventitial adipose tissue
Am J Physiol Heart Circ Physiol,
March 1, 2004;
286(3):
H1107 - H1113.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Offertaler, F.-M. Mo, S. Batkai, J. Liu, M. Begg, R. K. Razdan, B. R. Martin, R. D. Bukoski, and G. Kunos
Selective Ligands and Cellular Effectors of a G Protein-Coupled Endothelial Cannabinoid Receptor
Mol. Pharmacol.,
March 1, 2003;
63(3):
699 - 705.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|